Outpatient Patterns of Care and Longitudinal Intensity of Antiretroviral Therapy for HIV-Infected Drug Users

OBJECTIVE: To examine the association of drug users' outpatient patterns of care with subsequent intensity of antiretroviral therapy (ART). MATERIALS AND METHODS: Annual types of ART in 8897 New York State Medicaid drug users who were prescribed ART for > or =6 months in 1996 or 1997 were determined. From pharmacy claims, intensity was classified from changes in annual type of ART in 1996 to 97 and 1997 to 98 as: optimal (ie, on or starting highly active ART [HAART]), acceptable (ie, on or starting 2+ non-HAART drugs), or suboptimal (ie, none, <6 months, one drug, or change from HAART to non-HAART). In both 1996 and 1997, outpatient pattern of care was defined including regular medical care, regular drug treatment, both, and neither and categories of visits for HIV-focused care. Predictors of adequate ART intensity were examined among the group with suboptimal or adequate intensity (model 1) and predictors of optimal ART intensity among the group with adequate or optimal intensity (model 2). RESULTS: The adjusted odds ratios (AOR) of acceptable ART intensity in model 1 were increased for those with HIV-focused care (AOR, 2.9; 95% CI, 2.6, 3.3 for 4+ visits 1.7; 95% CI, 1.5, 1.9 for 1-3 visits) or regular medical care (AOR, 1.2 [1.1, 1.4]. Adjusted odds ratios (AOR) of optimal intensity in model 2 were increased for those with regular substance abuse care with (AOR, 1.4 [1.2, 1.7]) or without (AOR, 1.2 [1.1, 1.4]) regular medical care whereas HIV-focused visits had no effect. CONCLUSION: Care from an HIV-focused provider was predictive of a drug user receiving at least adequate intensity of ART for more than 2 years whereas regular drug abuse treatment, especially with regular medical care, was associated with optimal intensity of ART

Ambulatory care · Antiretroviral therapy · Family medicine · Health care · Human immunodeficiency virus (HIV) · Intensity (physics) · Medicaid · Odds ratio · Viral load · HIV, Drug Use, Sexual Risk · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Internal Medicine · Medicine · Pharmacy

• Mortality Rates and Causes of Death in a Cohort of HIV-Infected and Uninfected Women, 1993-1999

  Dawn K Smith•Journal of Urban Health•2003

  Incluir item

• Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users

  Barbara J Turner, Christine Laine et al.•Journal of General Internal…•2003

  Incluir item

• HIV Prevention Among Injection Drug Users

  David S Metzger•Journal of Urban Health•2003

  Incluir item

• Factors associated with use of HIV primary care among persons recently diagnosed with HIV

  M Anthony, M N Anthony et al.•AIDS Care•2007

  Incluir item

• Common mental health problems and antiretroviral therapy adherence

  Adriaan Nel, Ashraf Kagee•AIDS Care•2011

  Incluir item

• Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders

  Carmen L Masson, James L Sorensen et al.•AIDS Care•2004

  Incluir item

• Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/Aids patients

  Open Access•Valentina Dorea Lima, Viviane Lima et al.•Social Science & Medicine•2009

  Incluir item

• Highly Active Antiretroviral Therapy in a Large Urban Clinic

  Open Access•Gregory M Lucas, Richard E Chaisson et al.•Annals of Internal Medicine•1999

  Incluir item

• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

  Scott M Hammer, Kathleen E Squires et al.•New England Journal of Medicine•1997

  Incluir item

• Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users

  Steffanie A Strathdee•JAMA•1998

  Incluir item

• Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy

  Robert S Hogg•JAMA•1998

  Incluir item

• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

  Open Access•Ralph B D’agostino•Statistics in Medicine•1998

  Incluir item

• Access to antiretroviral treatment among French HIV infected injection drug users

  Patrizia Carrieri, M P Carrieri et al.•Journal of Epidemiology and…•1999

  Incluir item

• Providing medical care to methadone clinic patients

  Annie Umbricht-Schneiter, D H Ginn et al.•American Journal of Public Health•1994

  Incluir item

• Aids Specialist Versus Generalist Ambulatory Care for Advanced HIV Infection and Impact on Hospital Use

  Barbara J Turner, LINDA MCKEE et al.•Medical Care•1994

  Incluir item

• Antiretroviral Use and Pharmacy-Based Measurement of Adherence in Postpartum HIV-Infected Women

  Barbara J Turner, Craig J Newschaffer et al.•Medical Care•2000

  Incluir item